Evidence map›Paper›PMID 39795688›Full record

ArticleMaterials (Basel, Switzerland)2024

Optimization of MoNiCr Alloy Production Through Additive Manufacturing.

Michal Duchek, Daniela Nachazelova, Martina Koukolikova, Michal Brazda, Pavel Ludvik, Josef Strejcius, Zbysek Novy

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michal DuchekCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.
Daniela NachazelovaCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.ORCID 0000-0002-0050-6859
Martina KoukolikovaCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.ORCID 0000-0002-6161-6832
Michal BrazdaCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.ORCID 0000-0002-4982-9114
Pavel LudvikCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.
Josef StrejciusCentrum Vyzkumu Rez s.r.o., Hlavni 130, 250 68 Husinec, Czech Republic.ORCID 0009-0004-9819-7071
Zbysek NovyCOMTES FHT a.s., Prumyslova 995, 334 41 Dobrany, Czech Republic.

Funding

Ministry of Industry and Trade of the Czech Republic No. 11/2023The Ministry of Education, Youth and Sports CZ.02.01.01/00/23_021/0008433
6 · The paper itself

Abstract

One of the concepts behind Generation IV reactors is a molten salt coolant system, where the materials for the reactor itself and for the primary and secondary circuit components are subjected to extreme chemical and thermal stresses. Due to the unavailability of these materials, a nickel-molybdenum alloy known as MoNiCr has been developed in the Czech Republic. This paper discusses the manufacturing process for the MoNiCr alloy, covering conventional casting technology, forming, powder atomization, additive manufacturing (AM) using the directed energy deposition (DED-LB) process, and final heat treatment. Special attention was given to the quality of the input powders for additive manufacturing, particularly regarding the optimization of the chemical composition, which significantly influenced the quality of the additively manufactured components. AM enables the realization of complex structural designs that are critical for energy applications, despite the high susceptibility of the MoNiCr alloy to solidification cracking. Through AM, a test body was successfully produced with a maximum defect rate of 0.03% and the following mechanical properties: a yield strength (YS) of 279 MPa, an ultimate tensile strength (UTS) of 602 MPa, and an elongation (El) of 51%.

Indexed as

additive manufacturing (AM)directed energy deposition (DED-LB)miniature tensile test specimens (MTTs)molten salt reactor (MSR)nickel alloy MoNiCrsolidification cracking

Identifiers

PMID39795688
PMCPMC11722172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.